http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113616654-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113616654-B
titleOfInvention Use of GSK872 in the preparation of medicaments for the treatment of diseases caused by enterovirus 71 infection
abstract The invention discloses the use of GSK872 in preparing a medicine for treating diseases caused by enterovirus type 71 infection, and relates to the field of pharmacy. GSK872 is one of the protein kinase 3 inhibitors. The present invention verified for the first time that the protein kinase 3 inhibitor GSK872 can effectively inhibit the cytopathic effect caused by enterovirus type 71. The safe dosage of GSK872 for infants and young children with hand, foot and mouth disease caused by enterovirus type 71 infection provides guidance for the further development of medicines for the treatment of infants and young children with hand, foot and mouth disease. At the same time, the compound can be further developed as a medicine for the treatment of hand, foot and mouth disease. The dosage form It has a wide range of application prospects due to the diversification of drug delivery methods.
priorityDate 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56532
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15691190
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226545
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11035
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246240
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100004555
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413311082
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13728
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID535197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421183054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748160
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425140392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10313125

Total number of triples: 48.